Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Regular Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Growth

Add To Compare

30.661 (-0.353%)
NAV on September 08, 2025
Category Equity:
Sector - Healthcare
Total Assets 1,339 cr
Turnover Ratio 11.18%
Expense Ratio 2.10%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 2.37%
  • 1Y: -0.90%
  • 3M: 3.75%
  • 3Y: 23.12%
  • 6M: 11.30%
  • 5Y: 19.59%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since 12 months)
ISIN INF277K016A9
Fund Family Tata
P/E Ratio 39.82
P/B Ratio 6.05
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
CREDIT QUALITY (%)
AAA -
AA -
A -
BBB -
BB -
B -
Below B -
Unrated -
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 2.88
Beta 0.93
R-Squared 96.37
Info Ratio 0.78
Tracking Err 3.23
Sortino 1.746
Sharpe 0.987
Std Dev 15.945
Risk -
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
496.050 5.68% 3,963 cr 0.91% -


Other plans of Tata India Pharma & Healthcare

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund